Hypoxia-induced gene expression of aquaporin-4, cyclooxygenase-2 and hypoxia-inducible factor 1α in rat cortical astroglia is inhibited by 17β-estradiol and progesterone

Neuroendocrinology

Volumn 99, Issue 3-4, 2014, Pages 156-167

  Habib, Pardes ^a   Dang, Jon ^a   Slowik, Alexander ^a   Victor, Marion ^a   Beyer, Cordian ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Aquaporin 4; Astroglia; Cyclooxygenase 2; Estrogen; Hypoxia; Progesterone

Indexed keywords

AQUAPORIN 4; CYCLINE; CYCLOOXYGENASE 2; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR 30; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MEMBRANE P RECEPTOR ALPHA; OXYGEN; P RECEPTOR MEMBRANE COMPONENT 1 PROTEIN; PROGESTERONE; PROGESTERONE RECEPTOR A; PROTEIN; REACTIVE OXYGEN METABOLITE; STEROID RECEPTOR; UNCLASSIFIED DRUG; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN HYPOXIA; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG SELECTIVITY; GENE EXPRESSION; IN VITRO STUDY; INFLAMMATION; LETHALITY; MACROGLIA; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; ANALYSIS OF VARIANCE; ANIMAL; ANOXIA; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANOXIA; AQUAPORIN 4; ASTROCYTES; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CYCLOOXYGENASE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PROGESTERONE; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RNA, MESSENGER;

EID: 84908613123     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000362279     Document Type: Article

References (59)

1. Stein DG: Progesterone exerts neuroprotective effects after brain injury. Brain Res Rev 2008; 57: 386-397.
2. Dang J, Mitkari B, Kipp M, Beyer C: Gonadal steroids prevent cell damage and stimulate behavioral recovery after transient middle cerebral artery occlusion in male and female rats. Brain Behav Immun 2011; 25: 715-726.
3. Gibson CL, Constantin D, Prior MJ, Bath PM, Murphy SP: Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. Exp Neurol 2005; 193: 522-530.
4. Pawlak J, Brito V, Kuppers E, Beyer C: Regulation of glutamate transporters GLAST and GLT-1 expression in astrocytes by estrogen. Mol Brain Res 2005; 138: 1-7.
5. Arnold S, Beyer C: Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target. J Neurochem 2009; 110: 1-11.
6. Suzuki S, Brown CM, Wise PM: Neuroprotective effects of estrogens following ischemic stroke. Front Neuroendocrinol 2009; 30: 201-211.
7. Kipp M, Beyer C: Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis. Front Neuroendocrinol 2009; 30: 188-200.
8. Kipp M, Berger K, Clarner T, Dang J, Beyer C: Sex steroids control neuroinflammatory processes in the brain: relevance for acute ischaemia and degenerative demyelination. J Neuroendocrinol 2012; 24: 62-70.
9. Mor G, Nilsen J, Horvath T, Bechmann I, Brown S, Garcia-Segura LM, Naftolin F: Estrogen and microglia: a regulatory system that affects the brain. J Neurobiol 1999; 40: 484-496.
10. Loram LC, Sholar PW, Taylor FR, Wiesler JL, Babb JA, Strand KA, Berkelhammer D, Day HE, Maier SF, Watkins LR: Sex and estradiol influence glial pro-inflammatory responses to lipopolysaccharide in rats. Psychoneuroendocrinology 2012; 37: 1688-1699.
11. Arevalo MA, Santos-Galindo M, Bellini MJ, Azcoitia I, Garcia-Segura LM: Actions of estrogens on glial cells: implications for neuroprotection. Biochim Biophys Acta 2010; 1800: 1106-1112.
12. Johann S, Kampmann E, Denecke B, Arnold S, Kipp M, Mey J, Beyer C: Expression of enzymes involved in the prostanoid metabolism by cortical astrocytes after LPS-induced inflammation. J Mol Neurosci 2008; 34: 177-185.
13. Gunnarson E, Song Y, Kowalewski JM, Brismar H, Brines H, Cerami A, Andersson U, Zelenina M, Aperia A: Erythropoietin modulation of astrocyte water permeability as a component of neuroprotection. Proc Natl Acad Sci USA 2009; 106: 1602-1607.
14. Bajramovic JJ: Regulation of innate immune responses in the central nervous system. CNS Neurol Disord Drug Targets 2011; 10: 4-24.
15. Barreto G, White RE, Ouyang Y, Xu L, Giffard RG: Astrocytes: targets for neuroprotection in stroke. Cent Nerv Syst Agents Med Chem 2011; 11: 164-173.
16. Spence RD, Hamby ME, Umeda E, Itoh N, Du S, Wisdom AJ, Cao Y, Bondar G, Lam J, Ao Y, Sandoval F, Suriany S, Sofroniew MV, Voskuhl RR: Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc Natl Acad Sci USA 2011; 108: 8867-8872.
17. Sohrabji F, Bake S, Lewis DK: Age-related changes in brain support cells: implications for stroke severity. Neurochem Int 2013; 63: 291-301.
18. Ulbrich C, Zendedel A, Habib P, Kipp M, Beyer C, Dang J: Long-term cerebral cortex protection and behavioral stabilization by gonadal steroid hormones after transient focal hypoxia. J Steroid Biochem Mol Biol 2012; 131: 10-16.
19. Habib P, Dreymuller D, Ludwig A, Beyer C, Dang J: Sex steroid hormone-mediated functional regulation of microglia-like BV-2 cells during hypoxia. J Steroid Biochem Mol Biol 2013; 138: 195-205.
20. Habib P, Slowik A, Zendedel A, Johann S, Dang J, Beyer C: Regulation of hypoxia-induced inflammatory responses and M1-M2 phenotype switch of primary rat microglia by sex steroids. J Mol Neurosci 2014; 52: 277-285.
21. Kaur C, Sivakumar V, Zhang Y, Ling EA: Hypoxia-induced astrocytic reaction and increased vascular permeability in the rat cerebellum. Glia 2006; 54: 826-839.
22. Strauss KI: COX2 inhibitors for acquired brain injuries: is the time ripeCrit Care Med 2010; 38: 723-724.
23. Pawlak J, Karolczak M, Krust A, Chambon P, Beyer C: Estrogen receptor-alpha is associated with the plasma membrane of astrocytes and coupled to the MAP/Src-kinase pathway. Glia 2005; 50: 270-275.
24. Kipp M, Karakaya S, Johann S, Kampmann E, Mey J, Beyer C: Oestrogen and progesterone reduce expression of LPS-stimulated TNFalpha and interleukin-18 in mesencephalic and cortical astrocytes. J Neuroendocrinol 2007; 19: 819-822.
25. Bustin SA, Benes V, Nolan T, Pfaffl MW: Quantitative real-time RT-PCR-a perspective. J Mol Endocrinol 2005; 34: 597-601.
26. Maier O, Bohm J, Dahm M, Bruck S, Beyer C, Johann S: Differentiated NSC-34 motoneuron-like cells as experimental model for cholinergic neurodegeneration. Neurochem Int 2013; 62: 1029-1038.
27. Wagner D-C, Scheibe J, Glocke I, Weise G, Daten A, Boltze J, Kranz A: Object-based analysis of astroglial reaction and astrocyte subtype morphology after ischemic brain injury. Acta Neurobiol Exp 2012; 72: 79-87.
28. Stirone C, Duckles SP, Krause DK: Multiple forms of estrogen-receptor-a in cerebral blood vessels: regulation by estrogen. Am J Physiol Endocrinol Metab 2003; 284:E184-E192.
29. Leung Y-K, Mak P, Hassan S, Ho S-M: Estrogen receptor (ER)-isoforms: a key to understanding ER-signaling. Proc Natl Acad Sci USA 2006; 103: 13162-13167.
30. Dhandapani KM, Brann DW: Role of astrocytes in estrogen-mediated neuroprotection. Exp Gerontol 2007; 42: 70-75.
31. Arevalo MA, Santos-Galindo M, Acaz-Fonseca E, Azcoitia I, Garcia-Segura LM: Gonadal hormones and the control of reactive gliosis. Horm Behav 2013; 63: 216-221.
32. Johann S, Beyer C: Neuroprotection by gonadal steroid hormones in acute brain damage requires cooperation with astroglia and microglia. J Steroid Biochem Mol Biol 2013; 137: 71-81.
33. Neumann J, Gunzer M, Gutzeit HO, Ullrich O, Reymann KG, Dinkel K: Microglia provide neuroprotection after ischemia. FASEB J 2006; 20: 714-716.
34. Lakhan SE, Kirchgessner A, Hofer A: Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 2009; 7: 97.
35. Tichauer J, Saud K, von Bernhardi R: Modulation by astrocytes of microglial cell-mediated neuroinflammation: effect on the activation of microglial signaling pathways. Neuroimmunomodulation 2007; 14: 168-174.
36. Liu W, Tang Y, Feng J: Cross talk between activation of microglia and astrocytes in pathological conditions in the central nervous system. Life Sci 2011; 89: 141-146.
37. Sierra A, Gottfried-Blackmore A, Miner TA, McEwen BS, Bulloch K: Steroid hormone receptor expression and function in microglia. Glia 2008; 56: 659-674.
38. Jung-Testas I, Baulieu EE: Steroid hormone receptors and steroid action in rat glial cells of the central and peripheral nervous system. J Steroid Biochem Mol Biol 1998; 65: 243-251.
39. Meffre D, Labombarda F, Delespierre B, Chastre A, De Nicola AF, Stein DG, Schumacher M, Guennoun R: Distribution of membrane progesterone receptors alpha in the male mouse and rat brain and its regulation after traumatic brain injury. Neuroscience 2013; 231: 111-124.
40. Thomas P: Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions. Front Neuroendocrinol 2008; 29: 292-312.
41. Su C, Cunningham RL, Rybalchenko N, Singh M: Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (Pgrmc1)-dependent ERK5 signaling. Endocrinology 2012; 153: 4389-4400.
42. Lee E, Sidoryk-Wegrzynowicz M, Wang N, Webb A, Son DS, Lee K, Aschner M: GPR30 regulates glutamate receptor GLT-1 expression in rat primary astroglia. J Biol Chem 2012; 287: 26817-26828.
43. Zhang QR, Raz L, Wang R, Han D, De Sevilla L, Yang F, Vadlamundi RK, Brann DW: Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. J Neurosci 2009; 29: 13823-13836.
44. Charlier TD, Balthazart J: Modulation of hormonal signaling in the brain by steroid receptor coactivators. Rev Neurosci 2005; 16: 339-357.
45. Pantani N, Martin LA: Understanding response and resistance to oestrogen deprivation in ER-positive breast cancer. Mol Cell Endocrinol 2014; 282: 683-694.
46. Hardy DB, Janowski BA, Chen CC, Mendelson CR: Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer via ligand-dependent and ligand-independent mechanisms. Mol Endocrinol 2008; 22: 1812-1824.
47. Han EH, Kim HG, Hwang YP, Choi JH, Im JH, Park B, Yang JH, Jeong TC, Jeong HG: The role of cyclooxygenase-2-dependent signaling via syclic AMP response element activation on aromatase up-regulation by o, p ?-DDT in human breast cancer cells. Toxicol Lett 2010; 198: 331-341.
48. Freeman RS, Barone MC: Targeting hypoxiainducible factor (HIF) as a therapeutic strategy for CNS disorders. Curr Drug Targets CNS Neurol Disord 2005; 4: 85-92.
49. Mu D, Jiang X, Sheldon RA, Fox CK, Hamrick SE, Vexler ZS, Ferriero DM: Regulation of hypoxia-inducible factor 1alpha and induction of vascular endothelial growth factor in a rat neonate stroke model. Neurobiol Dis 2003; 14: 524-534.
50. Ye SH, Ou LC, Gean PW, Hung JJ, Chang WC: Selective inhibition of early-but not late-expressed HIF-1a is neuroprotective in rats after focal ischemic brain damage. Brain Pathol 2011; 21: 249-262.
51. Shenaq M, Kassem H, Peng C, Schafer S, Ding JY, Fredrickson V, Guthikonda M, Kreipke CW, Rafols JA, Ding Y: Neuronal damage and functional deficits are ameliorated by inhibition of aquaporin and Hif1a after traumatic brain injury. J Neurol Sci 2012; 323: 134-140.
52. Hara K, Kong DL, Sharp FR, Weinstein PR: Effect of selective inhibition of cyclooxygenase 2 on temporary focal cerebral ischemia in rat. Neurosci Lett 1998; 256: 53-56.
53. Baker AE, Brautigam VM, Watters JJ: Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta. Endocrinology 2004; 145: 5021-5032.
54. Zuloaga KL, O'Connor DT, Handa RJ, Gonzales RJ: Estrogen receptor beta dependent attenuation of cytokine-induced cyclooxygenase-2 by androgens in human brain vascular smooth muscle cells and rat mesenteric arteries. Steroids 2012; 77: 835-844.
55. Yang M, Gao F, Liu H, Yu WH, Sun SQ: Temporal changes in expression of aquaporin-3,-4,-5 and-8 in rat brains after permanent focal cerebral ischemia. Brain Res 2009; 1290: 121-132.
56. Shin JA, Choi JH, Choi YH, Park EM: Conserved aquaporin 4 levels associated with reduction of brain edema are mediated by estrogen in the ischemic brain after experimental stroke. Biochim Biophys Acta 2011; 1812: 1154-1163.
57. Rutkowsky JM, Wallace BK, Wise PM, O'Donnell ME: Effects of estradiol on ischemic factor-induced astrocyte swelling and AQP4 protein abundance. Am J Physiol Cell Physiol 2011; 301:C204-C212.
58. Guo Q, Sayeed I, Baronne LM, Hoffman SW, Guennoun R, Stein DG: Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp Neurol 2006; 198: 469-748.
59. Coomber B, Gibson CL: Sustained levels of progesterone prior to the onset of cerebral ischemia are not beneficial to female mice. Brain Res 2010; 1361: 124-132